Sickle SCAN® / Sickle SCAN® EZ

About BioMedomics

BioMedomics is a commercial-stage point-of-care diagnostics company, acquired by OraSure Technologies in November 2025, specializing in rapid tests for conditions like sickle cell disease. Its flagship product, Sickle SCAN®, is sold in over 40 countries, targeting critical gaps in healthcare access. The company leverages a robust IP portfolio and ISO-certified manufacturing to deliver lab-accurate results without complex equipment, aiming to advance health equity worldwide.

Therapeutic Areas